Titre : Dermatofibrosarcome

Dermatofibrosarcome : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Management
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dermatofibrosarcome : Questions médicales les plus fréquentes", "headline": "Dermatofibrosarcome : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dermatofibrosarcome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-05", "dateModified": "2025-03-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dermatofibrosarcome" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Fibrosarcome", "url": "https://questionsmedicales.fr/mesh/D005354", "about": { "@type": "MedicalCondition", "name": "Fibrosarcome", "code": { "@type": "MedicalCode", "code": "D005354", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.450.795.350" } } }, "about": { "@type": "MedicalCondition", "name": "Dermatofibrosarcome", "alternateName": "Dermatofibrosarcoma", "code": { "@type": "MedicalCode", "code": "D018223", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Aseel Sleiwah", "url": "https://questionsmedicales.fr/author/Aseel%20Sleiwah", "affiliation": { "@type": "Organization", "name": "Department of Plastic and Reconstructive Surgery, Southmead Hospital, Southmead Road, Bristol, BS10 5NB, UK. aseelnajeeb@yahoo.com." } }, { "@type": "Person", "name": "Yoshinao Oda", "url": "https://questionsmedicales.fr/author/Yoshinao%20Oda", "affiliation": { "@type": "Organization", "name": "Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. oda.yoshinao.389@m.kyushu-u.ac.jp." } }, { "@type": "Person", "name": "Katherine E Mallett", "url": "https://questionsmedicales.fr/author/Katherine%20E%20Mallett", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, U.S.A." } }, { "@type": "Person", "name": "Ryan M Claxton", "url": "https://questionsmedicales.fr/author/Ryan%20M%20Claxton", "affiliation": { "@type": "Organization", "name": "Alix School of Medicine, Mayo Clinic, Rochester, MN, U.S.A." } }, { "@type": "Person", "name": "Peter C Ferguson", "url": "https://questionsmedicales.fr/author/Peter%20C%20Ferguson", "affiliation": { "@type": "Organization", "name": "Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluation of Enterprise Accounting Data Management Based on Maturity Model.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36105631", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/3891475" } }, { "@type": "ScholarlyArticle", "name": "The Status of Data Management Practices Across German Medical Data Integration Centers: Mixed Methods Study.", "datePublished": "2023-11-08", "url": "https://questionsmedicales.fr/article/37938878", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/48809" } }, { "@type": "ScholarlyArticle", "name": "Data management in the digital health environment scale development study.", "datePublished": "2023-11-14", "url": "https://questionsmedicales.fr/article/37964225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-10205-3" } }, { "@type": "ScholarlyArticle", "name": "An Overview of the Fundamentals of Data Management, Analysis, and Interpretation in Quantitative Research.", "datePublished": "2023-03-02", "url": "https://questionsmedicales.fr/article/36868925", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.soncn.2023.151398" } }, { "@type": "ScholarlyArticle", "name": "Data Management 101 for drug developers: A peek behind the curtain.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37382299", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cts.13582" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par type histologique", "item": "https://questionsmedicales.fr/mesh/D009370" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du tissu conjonctif et des tissus mous", "item": "https://questionsmedicales.fr/mesh/D018204" }, { "@type": "ListItem", "position": 5, "name": "Sarcomes", "item": "https://questionsmedicales.fr/mesh/D012509" }, { "@type": "ListItem", "position": 6, "name": "Fibrosarcome", "item": "https://questionsmedicales.fr/mesh/D005354" }, { "@type": "ListItem", "position": 7, "name": "Dermatofibrosarcome", "item": "https://questionsmedicales.fr/mesh/D018223" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dermatofibrosarcome - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dermatofibrosarcome", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dermatofibrosarcome", "description": "Comment diagnostique-t-on un dermatofibrosarcome ?\nQuels examens complémentaires sont nécessaires ?\nQuels signes cliniques indiquent un dermatofibrosarcome ?\nLe dermatofibrosarcome peut-il être confondu avec d'autres tumeurs ?\nQuel rôle joue l'histopathologie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D018223?mesh_terms=Data+Management&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dermatofibrosarcome", "description": "Quels sont les symptômes d'un dermatofibrosarcome ?\nLe dermatofibrosarcome provoque-t-il des douleurs ?\nPeut-on observer des changements de couleur sur la lésion ?\nLes démangeaisons sont-elles fréquentes ?\nLa lésion peut-elle saigner ?", "url": "https://questionsmedicales.fr/mesh/D018223?mesh_terms=Data+Management&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dermatofibrosarcome", "description": "Peut-on prévenir le dermatofibrosarcome ?\nLes personnes à risque doivent-elles être surveillées ?\nL'exposition au soleil influence-t-elle le risque ?\nDes mesures de protection cutanée sont-elles recommandées ?\nLes vaccinations peuvent-elles aider à prévenir le cancer ?", "url": "https://questionsmedicales.fr/mesh/D018223?mesh_terms=Data+Management&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dermatofibrosarcome", "description": "Quel est le traitement principal du dermatofibrosarcome ?\nLa radiothérapie est-elle utilisée ?\nDes traitements médicamenteux sont-ils disponibles ?\nQuelle est l'importance de la surveillance post-opératoire ?\nPeut-on traiter le dermatofibrosarcome par chimiothérapie ?", "url": "https://questionsmedicales.fr/mesh/D018223?mesh_terms=Data+Management&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dermatofibrosarcome", "description": "Quelles sont les complications possibles du dermatofibrosarcome ?\nLe dermatofibrosarcome peut-il se propager ?\nComment gérer une récidive de dermatofibrosarcome ?\nLes cicatrices peuvent-elles poser problème après traitement ?\nY a-t-il des risques psychologiques associés ?", "url": "https://questionsmedicales.fr/mesh/D018223?mesh_terms=Data+Management&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dermatofibrosarcome", "description": "Quels sont les facteurs de risque du dermatofibrosarcome ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'âge influence-t-il le risque de dermatofibrosarcome ?\nLes infections virales sont-elles un facteur de risque ?\nLe sexe influence-t-il le risque de dermatofibrosarcome ?", "url": "https://questionsmedicales.fr/mesh/D018223?mesh_terms=Data+Management&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un dermatofibrosarcome ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et une biopsie pour analyse histologique." } }, { "@type": "Question", "name": "Quels examens complémentaires sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie comme l'IRM peuvent être utilisés pour évaluer l'extension tumorale." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un dermatofibrosarcome ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une lésion cutanée ferme, indolore, souvent pigmentée, qui évolue lentement." } }, { "@type": "Question", "name": "Le dermatofibrosarcome peut-il être confondu avec d'autres tumeurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec des lipomes ou d'autres tumeurs cutanées bénignes." } }, { "@type": "Question", "name": "Quel rôle joue l'histopathologie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'histopathologie permet de confirmer la nature maligne de la tumeur et son type histologique." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un dermatofibrosarcome ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une masse cutanée indolore, souvent avec des bords bien définis." } }, { "@type": "Question", "name": "Le dermatofibrosarcome provoque-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "En général, il est indolore, mais des douleurs peuvent survenir si la tumeur est compressive." } }, { "@type": "Question", "name": "Peut-on observer des changements de couleur sur la lésion ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la lésion peut présenter des variations de couleur, souvent brunâtre ou violacée." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les démangeaisons ne sont pas courantes, mais peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "La lésion peut-elle saigner ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La lésion peut saigner, surtout si elle est traumatisée ou si elle est en surface." } }, { "@type": "Question", "name": "Peut-on prévenir le dermatofibrosarcome ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais éviter les traumatismes cutanés peut aider." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles être surveillées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents familiaux ou des lésions cutanées doivent être surveillées." } }, { "@type": "Question", "name": "L'exposition au soleil influence-t-elle le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive au soleil peut augmenter le risque de certains cancers cutanés, mais pas spécifiquement du dermatofibrosarcome." } }, { "@type": "Question", "name": "Des mesures de protection cutanée sont-elles recommandées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, utiliser des écrans solaires et porter des vêtements protecteurs est conseillé." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir le cancer ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections liées à des cancers, mais pas spécifiquement le dermatofibrosarcome." } }, { "@type": "Question", "name": "Quel est le traitement principal du dermatofibrosarcome ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la chirurgie pour enlever complètement la tumeur." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La radiothérapie peut être utilisée en complément après la chirurgie pour réduire le risque de récidive." } }, { "@type": "Question", "name": "Des traitements médicamenteux sont-ils disponibles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements ciblés peuvent être envisagés dans les cas avancés ou récidivants." } }, { "@type": "Question", "name": "Quelle est l'importance de la surveillance post-opératoire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance est cruciale pour détecter rapidement toute récidive de la tumeur." } }, { "@type": "Question", "name": "Peut-on traiter le dermatofibrosarcome par chimiothérapie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La chimiothérapie n'est généralement pas efficace pour le dermatofibrosarcome, sauf cas avancés." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du dermatofibrosarcome ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la récidive locale et, dans de rares cas, des métastases." } }, { "@type": "Question", "name": "Le dermatofibrosarcome peut-il se propager ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Il a un faible potentiel de métastase, mais peut envahir les tissus voisins." } }, { "@type": "Question", "name": "Comment gérer une récidive de dermatofibrosarcome ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La récidive nécessite souvent une nouvelle intervention chirurgicale et un suivi étroit." } }, { "@type": "Question", "name": "Les cicatrices peuvent-elles poser problème après traitement ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cicatrices peuvent être inesthétiques et nécessiter des soins ou des interventions esthétiques." } }, { "@type": "Question", "name": "Y a-t-il des risques psychologiques associés ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diagnostic et le traitement peuvent entraîner du stress et de l'anxiété chez les patients." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du dermatofibrosarcome ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents de traumatismes cutanés, des maladies génétiques et l'exposition à des radiations." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de dermatofibrosarcome peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de dermatofibrosarcome ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le dermatofibrosarcome est plus fréquent chez les adultes jeunes, généralement entre 20 et 50 ans." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales, comme le virus de l'herpès, peuvent être associées à un risque accru." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de dermatofibrosarcome ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de différence significative entre les sexes concernant le risque de dermatofibrosarcome." } } ] } ] }

Sources (10000 au total)

The Status of Data Management Practices Across German Medical Data Integration Centers: Mixed Methods Study.

In the context of the Medical Informatics Initiative, medical data integration centers (DICs) have implemented complex data flows to transfer routine health care data into research data repositories f... Our study examines the current data management practices throughout the data life cycle within the Medical Informatics in Research and Care in University Medicine (MIRACUM) consortium. We present a fr... In this mixed methods study, we conducted semistructured interviews with stakeholders from 10 DICs between July and September 2021. We used a self-designed questionnaire that we tailored to the MIRACU... Our study provides insights into the data management practices at the MIRACUM DICs. We identify several traceability issues that can be partially explained with a lack of contextual information within... The data management maturity framework supports the production and dissemination of accurate and provenance-enriched data for secondary use. Our work serves as a catalyst for the derivation of an over...

Data management in the digital health environment scale development study.

This study aims to develop a scale that measures individuals' perceptions of privacy, security, use, sharing, benefit and satisfaction in the digital health environment.... Within the scope of the study, in the scale development process; The stages of literature review, creation of items, getting expert opinion, conducting a pilot study, ensuring construct and criterion ... The content validity of the research was carried out by taking expert opinions and conducting a pilot study. Exploratory factor analysis and confirmatory factor analysis were performed to ensure const... The Data Management in the Digital Health Environment Scale is a valid and reliable measurement tool that measures individuals' perceptions of privacy, security, use, sharing, benefit and satisfaction...

An Overview of the Fundamentals of Data Management, Analysis, and Interpretation in Quantitative Research.

To provide an overview of three consecutive stages involved in the processing of quantitative research data (ie, data management, analysis, and interpretation) with the aid of practical examples to fo... Published scientific articles, research textbooks, and expert advice were used.... Typically, a considerable amount of numerical research data is collected that require analysis. On entry into a data set, data must be carefully checked for errors and missing values, and then variabl... Developing capacity in the management, analysis, and interpretation of quantitative research data can have a multifaceted impact in enhancing nurses' confidence in understanding, evaluating, and apply...

Research Data Management and Data Sharing for Reproducible Research-Results of a Community Survey of the German National Research Data Infrastructure Initiative Neuroscience.

Science is changing: the volume and complexity of data are increasing, the number of studies is growing and the goal of achieving reproducible results requires new solutions for scientific data manage...

Standardization of an antimicrobial resistance surveillance network through data management.

The rapid spread of COVID-19 worldwide within 2 months demonstrated the vulnerability of the world's population to infectious diseases. In 2015, the Global Antimicrobial Resistance and Use Surveillanc... South Korea established Kor-GLASS (Korean-GLASS) to proactively monitor data quality and enable international collaborations. A unique feature of Kor-GLASS is the quality control center (QCC), which u... Since 2020, high-quality AMR data have indicated fluctuating antibiotic resistance rates in South Korea. This trend does not align with the decrease in antibiotic usage seen in humans but coincides wi... Although a standardized solution is not suitable for all countries, it must align with the local context and international standards. A centralized top-down management structure such as that of the QC...

Quality control data management with unity real-time in molecular virology.

Quality control (QC) is one component of an overarching quality management system (QMS) that aims at assuring laboratory quality and patient safety. QC data must be acceptable prior to reporting patie... A comprehensive workflow analysis was performed, with a focus on Epstein Barr Virus (EBV) and BKV quantitative viral load testing (Roche cobas 6800). The number of QC steps and time to complete each s... Our assessment of monthly QC data review revealed a total of 10 steps over 57 min when using Microsoft Excel, versus 6 steps over 11 min when using UnityRT. HIV-1 QC monitoring revealed subtle trendin... UnityRT consolidated QC analyses, monitoring, and tracking corrective actions. UnityRT was associated with significant time savings, which along with the interfaced feature of the QC capture and data ...